PROGRAM
Thursday 9th October 2025
0715 - 830 | Industry Breakfast Session Title: Precision Medicine in Breast Cancer: Necessity or Hype? International Guest Speaker: Prof Matteo Lambertini Local Speakers: Dr Belinda Yeo (Chair), A/Prof Dhanusha Sabanathan, A/Prof Nirmala Pathmanathan, Ms Jenny Gilchrist Description: Be part of a lively breakfast session where your peers will debate the reality behind precision medicine in breast cancer. Australia stands at the forefront of global discussions around biomarker-driven therapies — raising urgent questions about when tailored treatments are truly necessary, and when they may be more hype than help. Join international and local thought leaders as they tackle the latest evidence, explore the practical | |
0715 - 830 | Industry Breakfast Session Title: Optimising outcome in oncoplastic and high risk patients Speaker: Dr Chilton Chong (Breast Surgeon) | |
0845 - 1035 | Session 3 - Risk Assessment and screening strategies KEYNOTE: Talking about risk & uncertainty in genetic testing Next-Gen screening: a look at risk-stratified trials & protocols Is hormone therapy safe for high-risk women without breast cancer? Revolutionising BreastScreen: a year of live AI readings in NSW The Lancet Breast Cancer Commission - a roadmap for personalising breast cancer prevention Q&A panel | Chairs: Nick Repin, Jenny O'Sullivan Lesley Fallowfield (Video) Nehmat Houssami Rhea Liang Matthew Warner-Smith Kelly Anne Phillips |
1100 - 1245 | Session 4 - The Neoadjuvant multidisciplinary approach to management of breast cancer - the complexities Case Study 1 - Timing, sequencing and surgery: a complex case of high-risk breast cancer Case Study 2 - Young and ER-Positive: navigating the challenges of endocrine therapy intolerance The pathological assessment of neoadjuvant treated breast cancer Preoperative endocrine therapy as a functional biomarker in ER+ breast cancer Q&A panel | Chairs: Sanjeev Kumar, Peter Barry Tivya Kulasegaran Tivya Kulasegaran Elena Provenzano Belinda Yeo Matteo Lambertini, Ash Kothari. Elena Provenzano, Orit Kaidar-Person, Belinda Yeo, Owen Ung, Cameron Snell, Gillian Lamoury |
1245 - 1345 | Lunch in Trade Area | |
1245 - 1345 | ASBD AGM | |
1300 - 1345 | POSTER DISPLAY - AUTHORS PRESENT | |
1345 - 1530 | Session 5 Rapid fire - Abstracts and oral presentations KEYNOTE: The young premenopausal woman the issues facing fertility, survivorship, pregnancy and genetic implications Q & A Oral Presentations 1. Current breast lesion localisation techniques used in Australia and New Zealand - a shift from hookwire localisation to wire-free devices. 2. Does preoperative Breast MRI overestimate tumour size? 3. Current trends in incidence and histopathological upgrade rates of Ductal Carcinoma in Situ (DCIS) and Atypical Ductal Hyperplasia (ADH) in Queensland 4. Balancing Costs and Care: A Retrospective Cost-Efficiency Analysis of Indeterminate (B3) Breast Lesion Management and the Role of Vacuum-Assisted Excision Q & A 5. Changes in Treatment Recommendation for Patients with DCIS using a 7-Gene Predictive Biosignature: Analysis of the PREDICT Australia Study 6. Breast sensation following nipple-sparing mastectomy versus breast-conserving surgery: a mixed-methods study. 7. Development and Validation of a Hybrid Artificial Intelligence Chatbot-Based Decision Support Aid for Personalised Breast Cancer Treatment Planning 8. Prehabilitation Program During Neoadjuvant Treatment for Breast Cancer (PROActiveB): Codesign and Feasibility Study Q & A | Chairs: Cameron Snell, Sanjeev Kumar Matteo Lambertini Susan Bell Celina Ledgard Isobel Hymer Elizabeth Tan Yvonne Zissiadis Josette Mouawad Chu Luan Nguyen Susannah Graham |
1600 - 1730 | Session 6 - Innovation and Advances KEYNOTE: AI, Digital Biomarkers - integration of AI into breast cancer pathology Smarter Surgery: Strategies to lower re-excision rates Innovations in Imaging: The PET trial and next-generation PET modalities The therapeutic value of mainstream genetic testing Q&A panel | Chairs: Samriti Sood, Sandra O'Toole Elena Provenzano Ashutosh Kothari Remy Lim Annabel Goodwin |
1900 - 2300 | Conference Dinner - QT Hotel Sponsored by |
Saturday 11th October 2025
0715 - 830 | Industry Breakfast Session Title: Putting Patients First: Multidisciplinary strategies for managing adverse events in patients treated with KEYTRUDA® (pembrolizumab) regimen in high-risk early stage TNBC Speakers: Dr Maree Colosimo (Oncologist), Dr Lisa Ward (Endocrinologist), Dr Rebecca Moor (Oncologist) | |
0715 - 830 | Industry Breakfast Session Title: Bridging the Gap: A Multidisciplinary Morning on Regional and Remote Challenges in Breast Care Speakers: Dr Wendella Schimmer (Surgeon), Dr Nick Repin (Breast Radiologist), Dr Tuan Ha (Radiation Oncologist), Dr Virginia Baird (Women's Health GP), Stephanie Planner (Breast Sonographer) Description: Join Siemens Healthineers for an engaging breakfast panel discussion bringing together leading experts from across the breast care continuum - including breast imaging, surgery, and radiation oncology - to explore the current landscape of breast disease management in Australia and New Zealand. This multidisciplinary panel will explore the unique challenges faced by patients and clinicians in remote and regional communities, along with emerging trends and technologies in breast care that have the potential to bridge the access gap and promote greater equity for everyone, everywhere, sustainably. From disparities in access to leading technologies and workforce shortages, to diagnostic delays and infrastructure gaps, our panelists will share insights from the front lines and offer practical strategies to drive equitable outcomes across the healthcare system. This session promises thought-provoking discussion, cross-disciplinary perspectives, and a collaborative environment - over breakfast. Whether you're a clinician, policy maker, department administrator or healthcare innovator, this event offers a valuable opportunity to be part of the conversation shaping the future of breast care in our most underserved regions. | |
0845 - 1030 | Session 7 - Concurrent Sessions 7A Surgery and Radiotherapy - Updates in Management Global trends in training and practice of Oncoplastic Breast Surgery Sentinel Node Mapping: options beyond Tc99 TAD talk: a practical review of Axillary De-escalation Debate: The patients with residual axillary nodal disease after NAST should have complete Axillary Clearance Q&A panel 7B Medical Oncology - Estrogen receptor positive disease De-escalation in early HER2+ and TNBC: opportunities for tailored treatment HER2 is only half the story: the critical role of ER in HER2+ breast cancer What's next? Evolving treatment strategies after CDK4/6 inhibition progression All CLEAR - a strategy aiming at zero deaths from breast cancer Redefining phase 1: a first step, not a final hope Q&A panel | Chair: Marie Burke, Daniel de Viana Ashutosh Kothari Peter Barry Farid Meybodi For surgery: Ashutosh Kothari For radiotherapy: Orit Kaidar- Person Chairs: Maree Colosimo, Sanjeev Kumar Belinda Yeo Nicholas Wilcken Matteo Lambertini Christine Chaffer Dhanusha Sabanathan |
1100 - 1245 | Session 8 - Survivorship KEYNOTE: Key learnings from a real-world survivorship clinic Managing long term toxicities - bone matters Managing long term toxicities - heart matters Lymphoedema & Musculoskeletal issues update Nutrition, diets and supplements - navigating the plethora of information Q&A panel | Chairs: Angela Allen, Jenny Gilchrist Kim Kerin-Ayres Mike Lin Matthew Burrage Robyn Box Rewa Keegan |
1245 - 1330 | Lunch in Trade Area POSTER DISPLAY - AUTHORS PRESENT | |
1330 - 1500 | Session 9 - The last word on controversies panel Are we overtreating the low-risk cancer? High breast density: what now? Fibroepithelial lesions and predicting behaviour Radiotherapy to implant reconstruction and after skin sparing mastectomy Last chance questions - ask before it's too late! | Chairs: Maree Colosimo, Peter Chin Orit Kaidar-Person Nehmat Houssami Sandra O'Toole Orit Kaidar-Person |
1515 | Conference Close | Peter Chin & Maree Colosimo |
*Times are subject to change
Impact Events ABN 45 094 598 339
Address: Unit 24, Level 3, 2 Brandon Park Drive, Wheelers
Hill Victoria 3150 Australia
Phone: 1300 061 814 or +61 3 8657 4987 Email: info@impactevents.com.au